Your browser doesn't support javascript.
loading
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
Giorgi Rossi, Paolo; Lebeau, Annette; Canelo-Aybar, Carlos; Saz-Parkinson, Zuleika; Quinn, Cecily; Langendam, Miranda; Mcgarrigle, Helen; Warman, Sue; Rigau, David; Alonso-Coello, Pablo; Broeders, Mireille; Graewingholt, Axel; Posso, Margarita; Duffy, Stephen; Schünemann, Holger J.
Afiliação
  • Giorgi Rossi P; Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Lebeau A; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Canelo-Aybar C; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.
  • Saz-Parkinson Z; Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine, and Public Health, PhD Programme in Methodology of Biomedical Research and Public Health, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Quinn C; European Commission, Joint Research Centre (JRC), Ispra, Italy. zuleika.saz-parkinson@ec.europa.eu.
  • Langendam M; Instituto de Salud Carlos III, Health Technology Assessment Agency, Avenida Monforte de Lemos 5, Madrid, Spain. zuleika.saz-parkinson@ec.europa.eu.
  • Mcgarrigle H; St. Vincent's University Hospital, Dublin, Ireland.
  • Warman S; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Institute, Amsterdam, The Netherlands.
  • Rigau D; Cardiff and Vale UHB - General Surgery, Cardiff, UK.
  • Alonso-Coello P; Havyatt Lodge, Havyatt Road, Langford, North Somerset, UK.
  • Broeders M; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.
  • Graewingholt A; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.
  • Posso M; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Duffy S; Dutch Expert Centre for Screening, Nijmegen, the Netherlands.
  • Schünemann HJ; Radiologie am Theater, Paderborn, NRW, Germany.
Br J Cancer ; 124(9): 1503-1512, 2021 04.
Article em En | MEDLINE | ID: mdl-33597715
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Quimioterapia Adjuvante / Guias de Prática Clínica como Assunto / Recidiva Local de Neoplasia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Quimioterapia Adjuvante / Guias de Prática Clínica como Assunto / Recidiva Local de Neoplasia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália